Plasma Myostatin Levels Are Reduced in Patients with X-linked and Autosomal Dominant Forms of Centronuclear Myopathy
Plasma myostatin protein levels (pg/mL) from adult X-linked CNM (XL-CNM, MTM1 mutations) patients and autosomal dominant CNM (AD-CNM, DNM2 mutations; ages 19–61), and adult human control samples (aged 17–72). Each point represents one patient or control, n ≥ 4 per group. Results presented as violin plots. ∗p < 0.025, ∗∗∗∗p < 0.0001.